KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Equity Ratio (2016 - 2025)

West Pharmaceutical Services' Equity Ratio history spans 17 years, with the latest figure at 0.74 for Q3 2025.

  • For Q3 2025, Equity Ratio fell 0.75% year-over-year to 0.74; the TTM value through Sep 2025 reached 0.74, down 0.75%, while the annual FY2024 figure was 0.74, 2.14% down from the prior year.
  • Equity Ratio for Q3 2025 was 0.74 at West Pharmaceutical Services, roughly flat from 0.74 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.76 in Q3 2023 and bottomed at 0.67 in Q1 2021.
  • The 5-year median for Equity Ratio is 0.74 (2025), against an average of 0.73.
  • The largest annual shift saw Equity Ratio increased 6.3% in 2022 before it fell 2.14% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.7 in 2021, then grew by 5.33% to 0.74 in 2022, then grew by 1.34% to 0.75 in 2023, then fell by 2.14% to 0.74 in 2024, then increased by 0.95% to 0.74 in 2025.
  • Per Business Quant, the three most recent readings for WST's Equity Ratio are 0.74 (Q3 2025), 0.74 (Q2 2025), and 0.74 (Q1 2025).